Differential neutrophil activation before and after endotoxin infusion in enterally versus parenterally fed volunteers.
This study was done to determine whether or not increased susceptibility to infection seen in enterally versus parenterally fed patients was caused by altered neutrophil (PMN) responsiveness. To determine the differential effects of route of feeding on human PMN activation, plasma C3a levels, circulating PMN counts, PMN migration to leukotriene B4 (LTB4), the peptide, N-formyl-methionyl-leucyl-phenylalanine (FMLP) and zymosan activated serum (ZAS) and generation of LTB4 were assayed before and after and infusion of endotoxin. Nine normal volunteers were enterally (n=4) or parenterally (n=5) fed a diet sufficient to maintain body weight for seven days prior to a standard challenge of endotoxin. Samples were taken prior to the infusion and hourly thereafter for six hours. Prior to the injection of endotoxin, significant differences were seen in the two feeding groups. Plasma C3a levels, absolute circulating PMN counts and chemotaxis to LTB4 were all significantly (p less than 0.02) elevated in the enterally fed group. Generation of LTB4 was higher in the intravenously fed group at base line than the orally fed group (p less than 0.05). Plasma C3a levels rose in the enterally fed group, but not in the intravenously fed group, at two hours after infusion. Neutrophil counts rose in both feeding groups after endotoxin infusion; but the change in percentage was greater in the enterally fed group than in the intravenously fed group. Chemotaxis to FMLP and ZAS was not different during the study and did not differ between the two feeding can have significant impact on neutrophil function and that parenteral nutrition may impair host responsiveness.
Meyer
J
J
Department of Surgery, Cornell University Medical College, New York, New York.
Yurt
R W
RW
Duhaney
R
R
Hesse
D G
DG
Tracey
K J
KJ
Fong
Y
Y
Richardson
D
D
Calvano
S
S
Dineen
P
P
Shires
G T
GT
D002633:Chemotaxis / Q000187:drug effects; D003167:Complement Activation / Q000187:drug effects; D003176:Complement C3 / Q000032:analysis; D004731:Endotoxins / Q000008:administration & dosage*; D004750:Enteral Nutrition; D006854:Hydrocortisone / Q000097:blood; D007262:Infusions, Intravenous; D007700:Kinetics; D007781:Lactoferrin / Q000097:blood; D007958:Leukocyte Count / Q000187:drug effects; D007975:Leukotriene B4 / Q000096:biosynthesis; D008297:Male; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000493:pharmacokinetics; D009504:Neutrophils / Q000378:metabolism / Q000502:physiology*; D010288:Parenteral Nutrition; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D015054:Zymosan / Q000493:pharmacokinetics
D003176:Complement C3; D004731:Endotoxins; D014409:Tumor Necrosis Factor-alpha; D007975:Leukotriene B4; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015054:Zymosan; D007781:Lactoferrin; D006854:Hydrocortisone